FORT, L.P. - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 91 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FORT, L.P. ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q1 2020$581,000
-38.6%
9,491
-11.8%
0.13%
-22.2%
Q4 2019$946,000
+29.6%
10,761
+11.3%
0.17%
+22.8%
Q3 2019$730,000
+32.2%
9,672
+49.7%
0.14%
+28.3%
Q2 2019$552,000
-73.3%
6,460
-66.3%
0.11%
-74.6%
Q1 2019$2,071,000
-70.2%
19,158
-76.7%
0.42%
-74.5%
Q4 2018$6,948,000
-33.2%
82,094
-22.4%
1.64%
-29.6%
Q3 2018$10,400,000
-43.5%
105,795
-33.5%
2.32%
-46.6%
Q2 2018$18,401,000
+4.5%
159,053
-10.8%
4.35%
+2.8%
Q1 2018$17,601,000
-2.5%
178,259
+3.4%
4.23%
-0.3%
Q4 2017$18,053,000
-2.0%
172,411
+5.4%
4.25%
-6.3%
Q3 2017$18,428,000
-8.1%
163,526
-8.6%
4.53%
-9.4%
Q2 2017$20,059,000
-1.9%
179,005
+2.1%
5.00%
-7.4%
Q1 2017$20,438,000
+23.2%
175,257
+11.2%
5.40%
+15.6%
Q4 2016$16,589,000
+0.7%
157,584
+5.8%
4.68%
-17.6%
Q3 2016$16,468,000
-5.0%
149,014
+25.1%
5.67%
-19.8%
Q2 2016$17,337,000
+35.5%
119,072
+33.3%
7.08%
+31.2%
Q1 2016$12,796,000
+30.0%
89,329
+40.3%
5.40%
+15.0%
Q4 2015$9,841,000
+116.8%
63,675
+100.5%
4.69%
+100.5%
Q3 2015$4,539,00031,7642.34%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2020
NameSharesValueWeighting ↓
ISZO CAPITAL MANAGEMENT LP 1,104,168$154,849,00080.27%
Consonance Capital Management LP 378,372$53,063,0007.89%
Moab Capital Partners 93,133$13,061,0006.27%
Greywolf Capital Management LP 277,936$38,978,0005.77%
Perceptive Advisors 301,333$42,260,0004.15%
Valentine Capital Asset Management, Inc. 141,270$19,812,0003.81%
Raging Capital Management, LLC 253,236$35,514,0003.78%
Ativo Capital Management LLC 18,058$2,532,0001.10%
Geduld E E 8,000$1,122,0000.70%
Assured Investment Management LLC 192,389$26,981,0000.46%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders